Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepagina
  2. Aandelen
  3. Korea, Republiek van
  4. Korea Stock Exchange
  5. Seegene, Inc.
  6. Nieuws
  7. Persberichten
    A096530   KR7096530001

SEEGENE, INC.

(A096530)
  Rapport
slotkoers Korea Stock Exchange  -  25-11-2022
32200.00 KRW   -0.16%
14/11Seegene, Inc. Rapporteert winstresultaten voor het derde kwartaal en de negen maanden eindigend op 30 september 2022
CI
28/09Seegene, Inc. (KOSDAQ:A096530) kondigt een aandeleninkoop aan ter waarde van 50.000 miljoen KRW.
CI
28/09Seegene, Inc. staat een terugkoopregeling toe.
CI
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenFonds 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Communiquťs de presse de la sociťtť SEEGENE, INC.
12/08Seegene reports H1 2022 financial results
AQ
29/07Seegene unveils strategies for global expansion at 2022 AACC
AQ
19/07Seegene launches world's first In-life PCR campaign in Vietnam
AQ
29/06Seegene to pave way for PCR testing at local clinics with EU-approved multiplex test an..
AQ
28/06Seegene develops PCR test to detect monkeypox virus
AQ
25/05Seegene unveils '$12 PCR testing' initiative to help end COVID-19 pandemic
AQ
13/05Seegene reports first quarter 2022 financial results
AQ
26/04Seegene unveils world's first commercialized '3 Ct' PCR assay
AQ
17/03Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary
AQ
02/03Seegene appoints Richard Creager as CEO of U.S. subsidiary to bolster U.S. business
AQ
24/02Seegene unveils new assay optimized for on-site testing in 'living with Covid-19' era
AQ
17/02Seegene Announces Q4 and Full-Year 2021 Financial Results
AQ
10/02Seegene Signs Supply Deal to Deliver 4 million COVID-19 Tests to Brazil
AQ
19/01Seegene to Launch New COVID-19 PCR Test with a Reduced Turnaround Time Optimized for Ma..
AQ
17/01Seegene Continues to Support Israel's Effort to Manage the Omicron Variant With Timely ..
AQ
17/01Seegene's Allplex™ SARS CoV-2 FluA/FluB/RSV Assay approved under Health Canada's ..
AQ
12/01Seegene Unveils Blueprint for the Future of Molecular Diagnostics, Including Open Devel..
AQ
2021Seegene Airlifts 1.7 million COVID-19 Tests to Israel Battling the Omicron Variant by a..
AQ
2021Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant, its Stealt..
AQ
2021Seegene's High Multiplex PCR Assay Capable of Detecting New Omicron Variant
AQ
2021Seegene Announces Q3 2021 Earnings, Continuing COVID-Era Momentum
AQ
2021Seegene Opens New Subsidiary in Bogotá, Colombia, to Advance Regional COVID-19 Testing
AQ
2021Launch Of Seegene's Starlet-aios : All-in-One System Fulfills Critical Need for Fully Auto..
AQ
2021Seegene : Unveils Fully Automated Molecular Testing System at the 2021 AACC
AQ
2021Seegene : Receives CE-IVD Mark for Use of Combo Swab, a Self-Collection Device with Four C..
AQ
2021Seegene : Q2 2021 Earnings Show 11 Percent Revenue Growth, YoY
AQ
2021Seegene : Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Vari..
AQ
2021Seegene : announces partnership with Bio-Rad to develop diagnostic testing products for th..
AQ
2021Seegene : unveils "MOBILE STATION," for on-site routine testing at public-use facilities a..
AQ
2021Seegene : reports solid results in the first quarter of 2021 with KRW 351.8 billion
AQ
2021Seegene : introduces an exclusive diagnostic system for diagnosing COVID-19 variants at EC..
AQ
2021Seegene : signs exclusive supply agreement with the Kuwaiti government
AQ
2021Seegene : reports solid results in the first quarter of 2021 with KRW 351.8 billion
AQ
2021Seegene : Germany subsidiary supports the back-to-school initiative with its COVID-19 test..
AQ
2021Seegene : to supply COVID-19 diagnostic tests worth 16 mil. GBP to Scotland, triple the sa..
AQ
2021Seegene : Italy subsidiary secures public procurement for 7.15 million COVID-19 diagnostic..
AQ
2021Seegene : begins exporting its latest COVID-19 variant tests around the world to help cont..
AQ
2021Seegene : Latest COVID-19 Test Can Simultaneously Target 4 Genes of SARS-CoV-2 and Recogni..
AQ
2021Seegene : posts unprecedented Q4 and 2020 FY results; writes history by joining trillion-w..
AQ
2021Seegene : saliva test for COVID-19 is just as effective as NPS test
AQ
2021Seegene : develops world first COVID-19 variant test capable of identifying origins of vir..
AQ
2021Seegene : to advance business in Latin America in the New Year
AQ
2021Seegene : COVID-19 test with saliva sample collection feature now available in Europe
AQ
2020Seegene : COVID-19/FluA,B/RSV test with extraction-free feature now available in Europe
AQ
2020Hyundai's U.S. Actions in Response to Coronavirus (COVID-19)
AQ
2020Seegene : introduces a High-throughput 8-plex Test for Flu A, Flu B, RSV and COVID-19 with..
AQ
2020Hyundai's U.S. Actions in Response to Coronavirus (COVID-19)
AQ
2020Hyundai's U.S. Actions in Response to Coronavirus (COVID-19)
AQ
2020Hyundai's U.S. Actions in Response to Coronavirus (COVID-19)
AQ
2020Seegene : Exports 10 million Corona Tests to Brazil
AQ
2020Hyundai's U.S. Actions in Response to Coronavirus (COVID-19)
AQ
2020Hyundai's U.S. Actions in Response to Coronavirus (COVID-19)
AQ
2020Hyundai's U.S. Actions in Response to Coronavirus (COVID-19)
AQ
2020Covid-19 : More testing kits desperately needed - NCDC
AQ
2020Covid-19 : More testing kits desperately needed - NCDC
AQ
2020Hyundai's U.S. Actions in Response to Coronavirus (COVID-19)
AQ
2020Qiagen N : COVID-19 - More Testing Kits Desperately Needed - NCDC
AQ
2020Qiagen N : Govt's Dilemma - Can Lockdown Ease Amidst Rising Deaths and Spread of COVID-19?
AQ
2020Seegene : Allplex™ 2019-nCoV Assay receives FDA Emergency Use Authorization
AQ
2020Hyundai's U.S. Actions in Response to Coronavirus (COVID-19)
AQ
2020Seegene : exported 10 Million COVID-19 Diagnostic Tests to Over 60 countries
AQ
2020Hyundai Doubles Support for COVID-19 Drive-Thru Testing Locations Across America; Hyund..
AQ
2020Seegene : Receives Health Canada Approval for its COVID-19 Assay
AQ
2020Seegene : launches KFDA Approved COVID-19 Assay
AQ
2016Seegene : Technologies to Unleash Customized Multiplex PCR Solutions and Support for U.S. ..
BU
2015Seegene : and BD Form Worldwide Collaboration to Develop Multiplex Molecular Diagnostic As..
MW
2015Seegene : and QIAGEN Enter Into a Collaboration to Develop Multiplex Molecular Diagnostic ..
MW
2015Seegene : Receives CE Mark for First Comprehensive Real-Time PCR Gastrointestinal Infectio..
MW
2015Seegene : to Attend ECCMID 2015 Annual Meeting
MW
2015Seegene : Establishes U.S. Subsidiary
MW
2015Seegene : Receives Health Canada Approval for Its New Allplex(TM) Respiratory Molecular Te..
MW
2015Seegene : Receives FDA Clearance for Its Herpes Simplex Virus Molecular Test
MW
2015Seegene : to Present at the 33rd Annual J.P. Morgan Healthcare Conference
MW
2014Seegene : Announces Publication of MuDT(TM) Technology in Nature's Scientific Reports Jour..
MW
2014Seegene : Receives US Patent for TOCE(TM) Technology
MW
1  2Volgende
Volgende evenement op SEEGENE, INC.